{"date":"2025-07-23","count":14,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2025-07-23-2101-3vvomx","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-07-23","time":"21:01:44","subject":"代重要子公司Belite Bio, Inc公告受邀參加BTIG投資銀行舉辦之BTIG線上生技論壇(BTIG Virtual Biotechnology Conference)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-07-23 21:01，「代重要子公司Belite Bio, Inc公告受邀參加BTIG投資銀行舉辦之BTIG線上生技論壇(BTIG Virtua」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2025-07-23-1932-1u9cjnb","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2025-07-23","time":"19:32:19","subject":"公告本公司開發中新藥BRM411治療青光眼第I/IIb期人體臨床試驗(IND)已獲衛生福利部原則同意試驗進行","clause":"第10款","fact_date":"2025-07-23","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2025-07-23 19:32，「公告本公司開發中新藥BRM411治療青光眼第I/IIb期人體臨床試驗(IND)已獲衛生福利部原則同意試驗進行」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-07-23-1807-eybxwu","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-07-23","time":"18:07:49","subject":"本公司將於114年7月29日舉辦上櫃前業績發表會","clause":"第30款","fact_date":"2025-07-29","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-07-23 18:07，「本公司將於114年7月29日舉辦上櫃前業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2025-07-23-1748-10a0hoc","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2025-07-23","time":"17:48:08","subject":"公告本公司兩款泡棉傷口敷料通過日本醫藥品醫療機器綜合機構（PMDA）審查，取得第一類醫療器販售許可","clause":"第44款","fact_date":"2025-07-23","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2025-07-23 17:48，「公告本公司兩款泡棉傷口敷料通過日本醫藥品醫療機器綜合機構（PMDA）審查，取得第一類醫療器販售許可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-07-23-1721-18s4oyw","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-07-23","time":"17:21:38","subject":"公告增修本公司113年度股東會年報部分內容","clause":"第44款","fact_date":"2025-07-23","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-07-23 17:21，「公告增修本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-07-23-1718-usqq2l","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-07-23","time":"17:18:02","subject":"公告本公司調整113年度現金股利配息率","clause":"第31款","fact_date":"2025-07-23","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-07-23 17:18，「公告本公司調整113年度現金股利配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2025-07-23-1708-1djpca5","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2025-07-23","time":"17:08:58","subject":"本公司受邀參加臺灣生技產業高峰論壇","clause":"第12款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2025-07-23 17:08，「本公司受邀參加臺灣生技產業高峰論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-07-23-1641-mvk7ip","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-07-23","time":"16:41:37","subject":"公告本公司訂定除權息基準日等相關事宜","clause":"第31款","fact_date":"2025-07-23","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-07-23 16:41，「公告本公司訂定除權息基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-07-23-1636-1surenn","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-07-23","time":"16:36:39","subject":"公告本公司114年第2季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-23","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-07-23 16:36，「公告本公司114年第2季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2025-07-23-1615-54swv6","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-07-23","time":"16:15:42","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2025-07-23","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-07-23 16:15，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2025-07-23-1555-vqkii","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2025-07-23","time":"15:55:09","subject":"公告本公司註銷限制員工權利新股減資變更登記完成","clause":"第36款","fact_date":"2025-07-23","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2025-07-23 15:55，「公告本公司註銷限制員工權利新股減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2025-07-23-1352-xkr1ok","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2025-07-23","time":"13:52:36","subject":"公告本公司第三次買回庫藏股期間屆滿執行情形(更正實際買回期間)","clause":"第35款","fact_date":"2025-01-13","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2025-07-23 13:52，「公告本公司第三次買回庫藏股期間屆滿執行情形(更正實際買回期間)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-07-23-1345-fn5aok","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-07-23","time":"13:45:22","subject":"本公司受邀參加富邦證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-07-24","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-07-23 13:45，「本公司受邀參加富邦證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-07-23-1027-1fqkmsr","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-07-23","time":"10:27:27","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-07-23 10:27，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}